← FDA Drug Approvals (Drugs@FDA)

CABAZITAXEL

NDA · New Drug Application · Sponsor: SANDOZ · Approved 2023-10-27

Drug application

FDA Application #

NDA208715

Application type

New Drug Application

Brand name

CABAZITAXEL

Generic name

Cabazitaxel

Active ingredients

CABAZITAXEL

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

None (Tentative Approval)

Sponsor

SANDOZ

First approval

2023-10-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown